Cargando…
Clemastine improves hypomyelination in rats with hypoxic–ischemic brain injury by reducing microglia-derived IL-1β via P38 signaling pathway
BACKGROUND: Microglia activation is associated with the development of hypoxic–ischemic brain injury (HIBI). Neuroinflammation suppression might be a suitable therapeutic target in hypoxic oligodendrocyte injury. This study aims to determine whether clemastine can improve hypomyelination by suppress...
Autores principales: | Xie, Di, Ge, Xiaoli, Ma, Yanli, Tang, Jialong, Wang, Yang, Zhu, Yajie, Gao, Chengjin, Pan, Shuming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023767/ https://www.ncbi.nlm.nih.gov/pubmed/32061255 http://dx.doi.org/10.1186/s12974-019-1662-6 |
Ejemplares similares
-
Effect of Clemastine on Neurophysiological Outcomes in an Ovine Model of Neonatal Hypoxic-Ischemic Encephalopathy
por: Mike, Jana Krystofova, et al.
Publicado: (2023) -
Clemastine Induces an Impairment in Developmental Myelination
por: Palma, Ana, et al.
Publicado: (2022) -
Insights on therapeutic potential of clemastine in neurological disorders
por: Jiang, Sufang, et al.
Publicado: (2023) -
Repurposing Clemastine to Target Glioblastoma Cell Stemness
por: Sun, Michael A., et al.
Publicado: (2023) -
Clemastine Alleviates Depressive-Like Behavior Through Reversing the Imbalance of Microglia-Related Pro-inflammatory State in Mouse Hippocampus
por: Su, Wen-Jun, et al.
Publicado: (2018)